PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22379573-0	2012	Midazolam protects B35 neuroblastoma cells through Akt-phosphorylation in reactive oxygen species derived cellular injury.	Midazolam	0-9	AKT serine/threonine kinase 1	Homo sapiens	51-54	
22379573-7	2012	Western blotting was used for evaluating whether Akt-phosphorylation is involved in cell-protective effects of midazolam.	Midazolam	111-120	AKT serine/threonine kinase 1	Homo sapiens	49-52	
22379573-9	2012	On western blots, Akt-phosphorylation was induced during pretreatment with midazolam; it was diminished during co-treatment with LY-294002, an inhibitor of Akt-phosphorylation.	Midazolam	75-84	AKT serine/threonine kinase 1	Homo sapiens	18-21	
22379573-9	2012	On western blots, Akt-phosphorylation was induced during pretreatment with midazolam; it was diminished during co-treatment with LY-294002, an inhibitor of Akt-phosphorylation.	Midazolam	75-84	AKT serine/threonine kinase 1	Homo sapiens	156-159	
22379573-12	2012	CONCLUSIONS: Midazolam protects neuronal cells from GOX-induced ROS injury; this effect is mediated by an anti-apoptotic effect through Akt-phosphorylation.	Midazolam	13-22	AKT serine/threonine kinase 1	Homo sapiens	136-139	
34867807-11	2021	The loss in steroidogenic proteins at high midazolam levels may be mediated in part by the inactivation of protein kinase B/cAMP response element-binding protein (AKT/CREB) signaling pathway.	Midazolam	43-52	AKT serine/threonine kinase 1	Homo sapiens	163-166